Used in Clinical Haematology, DAWN High Risk Medication Monitoring Software, empowers nurse-led clinics to safely and efficiently manage MGUS or MPD patients. Our software …

DAWN Clinical Haematology software empowers nurse-led clinics to manage patients with long term conditions such as MGUS or MPD safely and efficiently. It supports protocol-driven …

2025年2月17日 · Intermediate- and high-risk MGUS should trigger bone marrow biopsy and bone imaging to detect overt MM and shorter monitoring intervals. Advanced molecular testing may …

2018年1月11日 · Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression …

2024年12月6日 · Focusing on the neurological manifestations of MGUS affecting the peripheral nervous system, we describe 3 illustrative cases from daily practice and discuss different …

MGUS is a condition in which abnormal plasma cells produce too much M protein in the blood. It is often found during routine blood tests. It is not. cancer. When MGUS turns into myeloma, …

意义未明单克隆免疫球蛋白血症（MGUS）是指血中存在单克隆免疫球蛋白（M蛋白<3g/dl），尿中少量或无M蛋白，骨髓浆细胞比例小于10%，无终末脏器损伤的一类良性疾病。

2023年5月19日 · This Good Practice Paper provides recommendations for the diagnosis, risk stratification and management of the monoclonal gammopathy of undetermined significance …

Monoclonal gammopathy of undetermined significance (MGUS) is one of the most common pre-malignant conditions in western countries with a prevalence of 3.2% in the Caucasian general …

This clinic uses a computer programme called “DAWN” to ensure that your blood results are reviewed by your healthcare team. You will need to have blood tests every six or twelve …